The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial

Diabetologia

Volumn 44, Issue 10, 2001, Pages 1215-1220

  Service, F J ^a   O'Brien, P C ^b  

^a Division of Endocrinology   (United States)

^b MAYO CLINIC   (United States)

Author keywords

DCCT; Glycaemia; HbA1c; Mean blood glucose; Retinopathy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CAPILLARIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FASTING; FEMALE; FOOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; RISK FACTORS;

EID: 0034771456     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100635     Document Type: Article

References (12)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
3. A 6-year, randomized, controlled trial comparing sulfonylurea, insulin and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy
4. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
5. Design and methodologic considerations for the feasibility phase
6. Simply automated determination of serum or plasma glucose in a hexokinase/glucose-6-phosphate dehydrogenase method
7. The M-value, an index of blood-sugar control in diabetics
8. Characteristics of glycemic stability
9. Mean amplitude of glycemic excursions, a measure of diabetic instability
10. Glycosylated hemoglobin and the risk of micro-albuminuria in patients with insulin-dependent diabetes mellitus
11. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial
12. Report of the expert committee on the diagnosis and classification of diabetes